United States — Nuts and Edible Seeds

← back to leaderboard

United States received 11 FDA import refusals in Nuts and Edible Seeds between 2023-Q4 and 2026-Q3. Volume peaked at 4 in 2025-Q2, with the trend falling year-on-year. The most-cited issues are filthy, aflatoxin, and nutrit lbl. No trade baseline is published for this commodity from United States, so no per-$1B rate is shown here.

Of these, 9 were hazard refusals and 2 were paperwork refusals.

Exporting from United States? Get an email when shipments from United States are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

1 2023-Q4 2023-Q4: 1 1 2024-Q1 2024-Q1: 1 2 2024-Q2 2024-Q2: 2 0 2024-Q3 2024-Q3: 0 0 2024-Q4 2024-Q4: 0 0 2025-Q1 2025-Q1: 0 4 2025-Q2 2025-Q2: 4 0 2025-Q3 2025-Q3: 0 1 2025-Q4 2025-Q4: 1 0 2026-Q1 2026-Q1: 0 1 2026-Q2 2026-Q2: 1 1 2026-Q3 2026-Q3: 1

By commodity, last 156 weeks

Commodity Rejections Per $1B US imports Most-cited hazard
Almond 7 filthy
Other-Nuts 2 poisonord
Pistachio 1 nutrit lbl
Walnut 1 filthy

Recent rejections